BioCentury | Mar 2, 2015
Finance

China's 3SBio plans 2nd IPO

...of China (known as "Class I" drugs in China's regulatory framework). In December, 3SBio acquired Shenzhen Sciprogen Bio-pharmaceutical Co. Ltd....
Items per page:
1 - 1 of 1
BioCentury | Mar 2, 2015
Finance

China's 3SBio plans 2nd IPO

...of China (known as "Class I" drugs in China's regulatory framework). In December, 3SBio acquired Shenzhen Sciprogen Bio-pharmaceutical Co. Ltd....
Items per page:
1 - 1 of 1